NR Tartrate | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,032 results for “NR Tartrate”

Trials

View all 709 →

NR-SAFE: Safety of High-dose Nicotinamide Riboside (NR) in Parkinson's Disease

20 participants · First posted Apr 25, 2022

NR Supplementation and Exercise

30 participants · First posted May 28, 2021

NR in Chemo-induced Peripheral Neuropathy

5 participants · First posted Aug 22, 2018

Drugs

View all 186 →

NR-14

NR-18014

NR-19022

Organizations

NASSER HANNA

Australia

UNIWERSYTECKI SZPITAL KLINICZNY NR 4 W LUBLINIE

Poland

UNIWERSYTECKI SZPITAL KLINICZNY NR 1 W LUBLINIE

Poland

News

View all 132 →

Niagen Bioscience Acquires Core NAD+ Patent Portfolio from Queen's University Belfast

ChromaDex Strengthens Patent Portfolio with Two New Continuation Patents for Nicotinamide Riboside Manufacturing

Novel Compounds NR and CoQ10 Show Promise in Improving Metabolism and Reducing Inflammation in CKD Patients

Page 1 of 104